Latest Articles
- Should I consider single-pill combination antihypertensive therapy for my patient with high blood pressure?
For many patients, starting treatment with a single-pill combination should be considered for the initial management of hypertension.
- Glucagon-like peptide-1 receptor agonists and pancreatitis: A reconcilable divorce
Early trials suggested a link between GLP-1 receptor agonists and pancreatitis, but recent large meta-analyses do not support a class-wide risk.
- Newer diabetes drugs: Surprising shared benefits and unique side effects
The shared beneficial effects of the SGLT2 inhibitors and the GLP-1 receptor agonists, drugs with distinct mechanisms of action, may have an anti-inflammatory explanation.
- Managing noninsulin glucose-lowering medications before surgery: A comparison of clinical practice guidelines
Recommendations for adjusting the treatment regimen of each class of noninsulin glucose-lowering agents before surgery are discussed.
- Odontogenic cutaneous fistula
A 55-year-old woman with a history of systemic lupus erythematosus and secondary Sjögren syndrome presented with a 2-year history of facial swelling and intermittent drainage from a skin lesion on her left jaw.
- Immunotherapy meets William Shakespeare
Immune checkpoint inhibitors are potentially life-saving therapies that can trigger a wide range of autoimmune pathology.